Thursday, November 21, 2024
Home Tags Cannabis research

cannabis research Related News

Advocacy group launches Australian Medicinal Cannabis Course Online

Advocacy group launches Australian Medicinal Cannabis Course Online

The recent Senate recommendations to substantially increase medical cannabis education for health professionals are being implemented by a leading advocacy group with the launch...
Formation of the Society of Cannabis Clinicians UK Chapter

Formation of the Society of Cannabis Clinicians UK Chapter

The Society of Cannabis Clinicians (SCC) is partnering with the Sapphire Institute for Medical Cannabis Education to form the SCC UK Chapter. SCC is a...
Evidence CBD may reduce cytokine storm and inflammation in COVID-19

Evidence CBD may reduce cytokine storm and inflammation in COVID-19

A new study has revealed early evidence that CBD may help to reduce cytokine storms and excessive lung inflammation in patients with COVID-19. Carried out...
Medical cannabis research and policy in Israel

Medical cannabis research and policy in Israel

Yuval Landschaft, Director of the Israeli Medical Cannabis Agency, outlines Israel’s regulatory approach to cannabis-based medical treatment. In recent years, there has been an increase...
Cannabis research, innovation, and policy in Australia

Cannabis research, innovation, and policy in Australia

Professor Jennifer Martin, Chair of Clinical Pharmacology at the University of Newcastle and Director of the Australia Centre for Cannabinoid Clinical and Research Excellence,...
The Center for Medicinal Cannabis Research with Dr Igor Grant

The Center for Medicinal Cannabis Research with Dr Igor Grant

In this article, Dr Igor Grant explores the work of the Center for Medicinal Cannabis Research. When the Center for Medicinal Cannabis Research at UC...
Cannabis medicine, education, and policy in Switzerland

Cannabis medicine, education, and policy in Switzerland

Professor Rudolf Brenneisen of the Swiss Society of Cannabis in Medicine tells us about medical cannabis in Switzerland. The Swiss Society of Cannabis in Medicine...
Normal people: cannabis and policy in Norway

Normal people: cannabis and policy in Norway

Ester Nafstad, Manager of Norwegian cannabis advocacy body Normal, tells MCN publication about the chapter’s goals and the need for reform of cannabis policy...
Cannaponics: cultivation and revitalisation in Western Australia

Cannaponics: cultivation and revitalisation in Western Australia

“This movement is more than just a phenomenon, it is a necessity. At Cannaponics Limited we are committed to leading a movement, not just...
Medical cannabis patients use fewer healthcare resources

Medical cannabis patients use fewer healthcare resources

A new study has revealed that medical cannabis patients use fewer healthcare resources and report improved quality of life. To date, there has been minimal...
Cannabis concentrates boost THC blood levels but do not get you ‘higher’

Cannabis concentrates boost THC blood levels but do not get you ‘higher’

A new study has shown that cannabis concentrates do increase THC levels in the blood, but do not actually have a stronger psychoactive impact...
Evidence still unclear on whether cannabis affects risk of stroke

Evidence still unclear on whether cannabis affects risk of stroke

Whether cannabis increases a person’s risk of suffering a stroke is still unclear. A new study explored whether there was a connection between recent...
First cannabis company in Malta obtains EU-GMP certification

First cannabis company in Malta obtains EU-GMP certification

Aphria Inc. has announced receipt of EU-GMP certification for its subsidiary – ASG Pharma Ltd in Malta – which positions the company as a...
Could cannabis terpene formulation treat COVID-19?

Could cannabis terpene formulation treat COVID-19?

A unique formulation of cannabis terpenes is being tested for its efficacy in treating viral infections, including COVID-19. The cannabis terpene formulation is uniquely dedicated...
NCCIH Deputy Director on cannabis research, safety concerns and policy

NCCIH Deputy Director on cannabis research, safety concerns and policy

NCCIH Deputy Director David Shurtleff, PhD, tells MCN about cannabis research, safety concerns and the impact of federal policy. Dr David Shurtleff is Deputy Director...
Oaksterdam University: cannabis legalisation, education and civil rights

Oaksterdam University: cannabis legalisation, education and civil rights

Cannabis campaigner and Oaksterdam University President Dale Sky Jones talks to MCN about cannabis legalisation, education and civil rights. Dale Sky Jones led the 2010...
Research and regulation in Canada with the CCIC

Research and regulation in Canada with the CCIC

Canadian Consortium for the Investigation of Cannabinoids (CCIC) Deputy Director Dr Lynda Balneaves speaks to MCN about education, research and patient safety. The Canadian Consortium...
Cannabis, neuropsychiatry and education with Dr Ilya Reznik

Cannabis, neuropsychiatry and education with Dr Ilya Reznik

Dr Ilya Reznik discusses the use of cannabinoid-based medicines for neuropsychiatric disorders and the barriers to prescribing CBD. Dr Ilya Reznik has published many original...
Wholly Hemp: putting phytocannabinoids in focus

Wholly Hemp: putting phytocannabinoids in focus

Wholly Hemp INC/Cannabidiol Life Brands, showcases the history and future of phytocannabinoid research in the USA and worldwide. In this article Jessica Arent, Chief Compliance...
New study to look at impact of COVID-19 on cannabis patients

New study to look at impact of COVID-19 on cannabis patients

A new study will be looking at the impact of the novel coronavirus – COVID-19 – on patients who use medical cannabis. A preliminary study...

Pin It on Pinterest